// App-Quantinova.ai

3067 : Italian cohort of nivolumab Expanded Access Programme (EAP): preliminary data from a real-world population.

Researchers

Presenter

  • Lucio Crino

Principal Investigators

  • Angelo Delmonte

  • Francesco Grossi

  • Filippo De Marinis

  • Francesca Sperandi

  • Fabiana Vitiello

  • Milena Vitali

  • Hector J. Soto Parra

  • Simone Scagnoli

  • Gabriele Minuti

  • Luana Calabro

  • Marcello Tiseo

  • Daniele Turci

  • Silvia Quadrini

  • Paola Antonelli

  • Anna Manzo

  • Irene Prediletto

  • Diana Giannarelli

  • Domenico Galetta

Medical Centers

  • Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy

  • Ospedale S Gerardo, Monza, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

  • Thoracic Oncology Division, European Institute of Oncology, Milan, Italy

  • Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy

  • UO DH Oncologico Ospedale Monaldi, Napoli, Italy

  • Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy

  • Medical Oncology, University Hospital Policlinico, Vittorio Emanuele, Catania, Italy

  • UOC Oncologia Policlinico Umberto I, Rome, Italy

  • Istituto Toscano Tumori, Department of Medical Oncology, Civil Hospital of Livorno, Livorno, Italy

  • Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy

  • Azienda Ospedaliero-Universitaria, Udine, Italy

  • Ospedale S Maria Delle Croci, Ravenna, Italy

  • Oncologia Medica,Ospedale "SS Trinita", Sora, Italy

  • SC Oncologia, ASST-Valle Olona, Busto Arstizio, Italy

  • NCI Naples, Naples, Italy

  • Oncology Unit I, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

  • Regina Elena National Cancer Institute, Rome, Italy

  • Medical Oncology Department, IRCCS Giovanni Paolo II, Bari, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • Unknown

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved